Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
Nature Communications|June 26, 2020
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemiaHend Abdelrasoul, Anila Vadakumchery, Markus Werner, et al.
BMC Cancer|May 3, 2022
Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocolLinea Natalie Toksvang, Bodil Als-Nielsen, Christopher Bacon, et al.
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Haematologica|October 29, 2017
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologiesGiovanni Cazzaniga, Paola De Lorenzo, Julia Alten, et al.
Haematologica|November 24, 2018
Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group reportBenjamin O Wolthers, Thomas L Frandsen, Chirag J Patel, et al.
Nature Communications|November 26, 2021
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression programSiobhan Rice, Thomas Jackson, Nicholas T Crump, et al.
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Communications Biology|January 16, 2021
CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemiaLennart Lenk, Michela Carlet, Fotini Vogiatzi, et al.
Leukemia|May 18, 2022
Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolutionPaulina Richter-Pechańska, Joachim B Kunz, Tobias Rausch, et al.
EMBO Molecular Medicine|August 6, 2020
Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursorsBüşra Erarslan-Uysal, Joachim B Kunz, Tobias Rausch, et al.
Pageof 18